dactinomycin and Granulocytic Leukemia, Chronic

dactinomycin has been researched along with Granulocytic Leukemia, Chronic in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's5 (62.50)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FIELD, JB1
Lin, MF; Mai, WY1
Beck, J; Ehninger, G; Frese, G; Gekeler, V; Handgretinger, R; Neumann, M; Niethammer, D; Noller, A; Probst, H; Wilisch, A1
Herwig, S; Ma, Y; Su, Q; Tempst, P; Zhang, W1
Bertoglio, J; Bréard, J; Issaad, C; Léglise, MC; Pallardy, M; Roger, R; Turhan, AG1
Ezawa, H; Harigaya, K; Ishii, G; Mikata, A; Nakajima, N1
Kharbanda, SM; Kufe, DW; Sherman, ML1
Bankhurst, AD; Cutts, JL; Scallen, TJ; Watson, J1

Other Studies

8 other study(ies) available for dactinomycin and Granulocytic Leukemia, Chronic

ArticleYear
The carcinolytic effect of actinomycin C; a report of clinical studies.
    California medicine, 1957, Volume: 86, Issue:5

    Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Biomedical Research; Dactinomycin; Hodgkin Disease; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Multiple Myeloma; Neoplasms; Neuroblastoma

1957
Induction of apoptosis by homoharringtonine in G1 phase human chronic myeloid leukemic cells.
    Chinese medical journal, 2005, Mar-20, Volume: 118, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cycloheximide; Dactinomycin; G1 Phase; Harringtonines; Homoharringtonine; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive

2005
Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias.
    Annals of hematology, 1994, Volume: 69 Suppl 1

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Blast Crisis; Blotting, Northern; Carrier Proteins; Dactinomycin; DNA Topoisomerases, Type II; Drug Resistance; Gene Expression; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Glycoproteins; Molecular Sequence Data; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured

1994
Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells.
    Blood, 1996, Jan-01, Volume: 87, Issue:1

    Topics: Acetamides; Biomarkers; Blood Proteins; Cell Differentiation; Cycloheximide; Cytokines; Dactinomycin; Defensins; Dimethyl Sulfoxide; Dimethylformamide; DNA, Complementary; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Genistein; Granulocyte Colony-Stimulating Factor; Granulocytes; HL-60 Cells; Humans; Interferon-gamma; Isoflavones; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphocytes; Lymphoma, Large B-Cell, Diffuse; Neoplasm Proteins; Recombinant Proteins; RNA Processing, Post-Transcriptional; RNA, Messenger; Tetradecanoylphorbol Acetate; Time Factors; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1996
BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells.
    Blood, 1996, Feb-01, Volume: 87, Issue:3

    Topics: Apoptosis; Camptothecin; Cycloheximide; Cytotoxicity, Immunologic; Dactinomycin; DNA Damage; DNA, Neoplasm; Etoposide; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Puromycin; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1996
12-O-tetradecanoylphorbol-13-acetate (TPA) downregulates expression of CD30 in erythroleukemia cell line K562.
    Hematological oncology, 1997, Volume: 15, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antigens, Neoplasm; Blast Crisis; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Half-Life; Humans; Ki-1 Antigen; Leukemia, Erythroblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nucleic Acid Synthesis Inhibitors; Protein Kinase C; Protein Synthesis Inhibitors; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1997
Transcriptional regulation of c-jun gene expression by arabinofuranosylcytosine in human myeloid leukemia cells.
    The Journal of clinical investigation, 1990, Volume: 86, Issue:5

    Topics: Actins; Blotting, Northern; Cell Cycle; Cell Differentiation; Cytarabine; Dactinomycin; DNA-Binding Proteins; Gene Expression Regulation; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-jun; Proto-Oncogenes; Tetradecanoylphorbol Acetate; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured

1990
Role of mevalonic acid in the regulation of natural killer cell cytotoxicity.
    Journal of cellular physiology, 1989, Volume: 139, Issue:3

    Topics: Cell Line; Cell Survival; Cells, Cultured; Cholesterol; Cycloheximide; Cytotoxicity, Immunologic; Dactinomycin; Dolichols; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Killer Cells, Natural; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lovastatin; Mevalonic Acid; Sterols

1989